Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)
NCT06506773 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79
Last updated 2025-12-31
Summary
The purpose of the study is to evaluate the natural history of exocrine pancreatic function by assessing Fecal elastase-1 (FE-1) in infants with CF during their first year of life.
Conditions
Sponsors & Collaborators
-
Vertex Pharmaceuticals Incorporated
lead INDUSTRY
Eligibility
- Max Age
- 6 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-07-09
- Primary Completion
- 2025-11-27
- Completion
- 2025-11-27
Countries
- United States
- Australia
- Canada
- Czechia
- Germany
- Italy
- New Zealand
- Poland
- Spain
- Switzerland
- United Kingdom
Study Locations
More Related Trials
-
Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic Fibrosis
NCT04026360 ·Status: RECRUITING
-
Diagnosis and Treatment of Patients With Cystic Fibrosis
NCT00001223 ·Status: TERMINATED
-
Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of Age
NCT05882357 ·Status: COMPLETED ·Phase: PHASE3
-
Regional Phenotyping of CF and Non-CF Bronchiectasis
NCT04793867 ·Status: RECRUITING
-
Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening
NCT02270476 ·Status: RECRUITING
-
Determinants of Early Cystic Fibrosis Lung Disease
NCT03579173 ·Status: COMPLETED
-
Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)
NCT00880100 ·Status: COMPLETED ·Phase: PHASE3
-
Viral Pathogenesis of Early Cystic Fibrosis Lung Disease
NCT01973192 ·Status: COMPLETED
-
Tissue Collection From People With Cystic Fibrosis
NCT00015756 ·Status: COMPLETED
-
Using Rheological Methods to Characterize Cystic Fibrosis (CF) Sputum and the Effects of Mucoactive Agents
NCT00758771 ·Status: COMPLETED
-
Detection of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity in Rectal Tissues From Human Subjects
NCT01078740 ·Status: COMPLETED
-
Ocular Surface Changes in Patients With Cystic Fibrosis
NCT00345280 ·Status: UNKNOWN
-
Choline Nutritional Status Of Children With Cystic Fibrosis X-Sectional Study
NCT01150136 ·Status: COMPLETED
-
Early Assessment of Respiratory Function, Inflammation and Bronchial Reshuffle Among Newborns Screened for Cystic Fibrosis
NCT02883816 ·Status: COMPLETED ·Phase: NA
-
Real-world Efficacy and Safety of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy in Adult Patients With Cystic Fibrosis (CF)
NCT05526027 ·Status: UNKNOWN ·Phase: NA
-
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes
NCT05385211 ·Status: COMPLETED
-
Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic Fibrosis
NCT04397809 ·Status: COMPLETED
-
Breath Analysis in in Adults With Cystic Fibrosis (CF)
NCT02209571 ·Status: COMPLETED ·Phase: NA
-
Muscle Endurance in Children With Cystic Fibrosis
NCT06812793 ·Status: COMPLETED
-
Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
NCT00775528 ·Status: COMPLETED ·Phase: PHASE3
-
Population Pharmacokinetics of Elexacaftor-tezacaftor-ivacaftor in a Paediatric Population
NCT07303621 ·Status: RECRUITING
-
Magnetic Resonance Imaging (MRI) for Early Diagnosis of Cystic Fibrosis (CF)
NCT00760071 ·Status: COMPLETED
-
Genetics of Insulin and Incretins in Cystic Fibrosis
NCT01852448 ·Status: RECRUITING
-
Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF
NCT05639556 ·Status: ACTIVE_NOT_RECRUITING
-
Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients
NCT00663975 ·Status: WITHDRAWN ·Phase: NA